DE69917717D1 - C11 carbamates from antibacterial macrolides - Google Patents

C11 carbamates from antibacterial macrolides

Info

Publication number
DE69917717D1
DE69917717D1 DE69917717T DE69917717T DE69917717D1 DE 69917717 D1 DE69917717 D1 DE 69917717D1 DE 69917717 T DE69917717 T DE 69917717T DE 69917717 T DE69917717 T DE 69917717T DE 69917717 D1 DE69917717 D1 DE 69917717D1
Authority
DE
Germany
Prior art keywords
compounds
formula
relates
carbamates
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69917717T
Other languages
German (de)
Other versions
DE69917717T2 (en
Inventor
Hengmiao Cheng
Michael Anthony Letavic
Carl Bernard Ziegler
Jason Kenneth Dutra
Peter Bertinato
Brian Scott Bronk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE69917717D1 publication Critical patent/DE69917717D1/en
Publication of DE69917717T2 publication Critical patent/DE69917717T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This invention relates to compounds of the formula <CHEM> and to pharmaceutically acceptable salts thereof. The compounds of formula 1 are potent antibacterial agents that may be used to treat various bacterial infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial infections by administering the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1 and to intermediates useful in such preparation.
DE69917717T 1998-08-19 1999-07-29 C11 carbamates from antibacterial macrolides Expired - Fee Related DE69917717T2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9707598P 1998-08-19 1998-08-19
US97075P 1998-08-19
US10478598P 1998-10-19 1998-10-19
US104785P 1998-10-19

Publications (2)

Publication Number Publication Date
DE69917717D1 true DE69917717D1 (en) 2004-07-08
DE69917717T2 DE69917717T2 (en) 2004-09-23

Family

ID=26792507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69917717T Expired - Fee Related DE69917717T2 (en) 1998-08-19 1999-07-29 C11 carbamates from antibacterial macrolides

Country Status (10)

Country Link
US (1) US6043227A (en)
EP (1) EP0984019B1 (en)
JP (1) JP2000063397A (en)
AT (1) ATE268337T1 (en)
BR (1) BR9903737A (en)
CA (1) CA2280328C (en)
DE (1) DE69917717T2 (en)
DK (1) DK0984019T3 (en)
ES (1) ES2220008T3 (en)
PT (1) PT984019E (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
WO2000071557A1 (en) * 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
WO2001070239A1 (en) * 2000-03-22 2001-09-27 Thomas Jefferson University Use of azithromycin for infections with leishmania
US20040186063A1 (en) * 2002-02-15 2004-09-23 Hans-Jurgen Gutke Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003215245A1 (en) * 2002-02-15 2003-09-09 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
NZ535354A (en) 2002-02-15 2008-01-31 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003211113B2 (en) * 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
CN1665831A (en) 2002-07-08 2005-09-07 普利瓦研究院有限公司 Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory, antienoplastic and antiviral active molecules
NZ537716A (en) * 2002-07-08 2007-05-31 Glaxosmithkline Zagreb Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
RS20050008A (en) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., New compounds,compositions and methods for treatment of inflammatory diseases and conditions
AU2006274197A1 (en) * 2005-07-26 2007-02-01 Merckle Gmbh Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
CN101423539B (en) * 2008-12-09 2011-04-27 山东大学 4'',11-diamino formic ether azithromycin derivates, preparation method and medicament composition thereof
FR2995605B1 (en) * 2012-09-18 2014-09-19 Sanofi Sa MACROLIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
CN104844671B (en) * 2015-05-19 2017-07-04 山东大学 11 O ''-aralkyl carbamic acid ester clarithomycin derivatives and preparation method and application

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4464527A (en) * 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
KR880009960A (en) * 1987-02-24 1988-10-06 데이빗 로버츠 Chemical compound
US5350839A (en) * 1990-10-15 1994-09-27 Taisho Pharmaceutical Co., Ltd. 2'-position modified compound of erythromycin or its derivative
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
HN1998000074A (en) * 1997-06-11 1999-01-08 Pfizer Prod Inc DERIVATIVES FROM MACROLIDES C-4 SUBSTITUTED
HN1998000086A (en) * 1997-06-11 1999-03-08 Pfizer Prod Inc DERIVATIVES OF 9 - DESOFO - 9 AZA - 9A - HOMOERITROMICINA A - C - 4 SUBSTITUTED.
HRP970714B1 (en) * 1997-12-31 2003-08-31 Pliva Pharm & Chem Works Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.

Also Published As

Publication number Publication date
JP2000063397A (en) 2000-02-29
ES2220008T3 (en) 2004-12-01
DE69917717T2 (en) 2004-09-23
DK0984019T3 (en) 2004-08-30
EP0984019A1 (en) 2000-03-08
PT984019E (en) 2004-08-31
US6043227A (en) 2000-03-28
BR9903737A (en) 2000-09-19
CA2280328A1 (en) 2000-02-19
CA2280328C (en) 2005-07-26
EP0984019B1 (en) 2004-06-02
ATE268337T1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
EA199901014A1 (en) C-4 &#34;-SUBLISHED MACROLIDE DERIVATIVES
DE69917717D1 (en) C11 carbamates from antibacterial macrolides
MY123354A (en) 4&#34;-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
DE69716810D1 (en) 2,3-disubstituted-(5,6) -heteroarylkondensierte-pyrimidin-4-one
GT199900208A (en) CARBAMATO AND CARBAZATO CETÒLID ANTIBIOTICS.
MY122353A (en) 13-membered azalides and their use as antibiotic agents
ATE277062T1 (en) NEW MACROLIDE DERIVATIVES
DE60102171D1 (en) Ketolidantibiotika
PT1167376E (en) MACROLIDOS ANTIBIOTICS
BR9902049A (en) Derivatives 9a, 11b-dehydro of 9-oxime-3-keto-6-o-metilithithromycin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee